Lucie Boerrigter

Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers

Claudia Ruivenkamp, Tom van Wezel, Carlo Zanon et al. · Nature Genetics · 2002 · 261 citations

Medicine, Genetics, Molecular Genetics +10

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

Nico van Zandwijk, Alexandre Mathy, Lucie Boerrigter et al. · Annals of Oncology · 2006 · 151 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

Mirjam Crul, G.J.M. de Klerk, M. Swart et al. · Journal of Clinical Oncology · 2002 · 130 citations

Medicine, Oncology, Pharmacology +15

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.

Sjoerd Rodenhuis, Lucie Boerrigter, Bert Top et al. · Journal of Clinical Oncology · 1997 · 95 citations

Medicine, Oncology, Carcinogenesis +10

Goblet cell carcinoid of the appendix: a specific type of carcinoma

S. van Eeden, G. Johan A. Offerhaus, A. A. M. Hart et al. · Histopathology · 2007 · 94 citations

Medicine, Oncology, Pathology +17